Daisuke Tenmizu

Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion

Daisuke Tenmizu, Yasuhisa Endo, K. Noguchi et al. · Xenobiotica · 2004 · 45 citations

Medicine, Pharmacokinetics, Pharmacology +15

Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors

Mei Tang, Amit Garg, Peter L. Bonate et al. · Clinical Pharmacokinetics · 2024 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

THE CANINE CYP1A2 DEFICIENCY POLYMORPHISM DRAMATICALLY AFFECTS THE PHARMACOKINETICS OF 4-CYCLOHEXYL-1-ETHYL-7-METHYLPYRIDO[2,3-D]-PYRIMIDINE-2-(1H)-ONE (YM-64227), A PHOSPHODIESTERASE TYPE 4 INHIBITOR

Daisuke Tenmizu, Kiyoshi Noguchi, Hidetaka Kamimura et al. · Drug Metabolism and Disposition · 2006 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Elucidation of the Effects of the CYP1A2 Deficiency Polymorphism in the Metabolism of 4-Cyclohexyl-1-ethyl-7-methylpyrido[2,3-d]pyrimidine-2-(1H)-one (YM-64227), a Phosphodiesterase Type 4 Inhibitor, and Its Metabolites in Dogs

Daisuke Tenmizu, Kiyoshi Noguchi, Hidetaka Kamimura · Drug Metabolism and Disposition · 2006 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +16